Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bourgeat

Showing results (171-180 of 256) with videos related to

Pageof 26
Sort By:
Neuroimage|August 18, 2023
Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studiesAriane Bollack, Pawel J Markiewicz, Alle Meije Wink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 30, 2026
Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypesTenielle Porter, Ayeisha Milligan Armstrong, Eleanor K O'Brien, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Frontiers in Aging Neuroscience|December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle StudySamantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Annals of Neurology|April 8, 2010
Relationship between atrophy and beta-amyloid deposition in Alzheimer diseaseGaël Chételat, Victor L Villemagne, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Christopher Buckley, Mark R Battle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methodsAleksandar Jovalekic, Núria Roé-Vellvé, Norman Koglin, et al.
Journal of Medicinal Chemistry|February 26, 2000
Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitorsC R Ganellin, P B Bishop, R B Bambal, et al.
Radiology. Artificial Intelligence|December 18, 2024
A Machine Learning Model to Harmonize Volumetric Brain MRI Data for Quantitative Neuroradiologic Assessment of Alzheimer DiseaseDamiano Archetti, Vikram Venkatraghavan, Béla Weiss, et al.
Alzheimer'S Research & Therapy|April 17, 2021
Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methodsJames D Doecke, Cindy Francois, Christopher J Fowler, et al.
Pageof 26

Showing results (171-180 of 256) with videos related to

Sort By:
Pageof 26
Neuroimage|August 18, 2023
Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studiesAriane Bollack, Pawel J Markiewicz, Alle Meije Wink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 30, 2026
Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypesTenielle Porter, Ayeisha Milligan Armstrong, Eleanor K O'Brien, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Frontiers in Aging Neuroscience|December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle StudySamantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Annals of Neurology|April 8, 2010
Relationship between atrophy and beta-amyloid deposition in Alzheimer diseaseGaël Chételat, Victor L Villemagne, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Christopher Buckley, Mark R Battle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methodsAleksandar Jovalekic, Núria Roé-Vellvé, Norman Koglin, et al.
Journal of Medicinal Chemistry|February 26, 2000
Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitorsC R Ganellin, P B Bishop, R B Bambal, et al.
Radiology. Artificial Intelligence|December 18, 2024
A Machine Learning Model to Harmonize Volumetric Brain MRI Data for Quantitative Neuroradiologic Assessment of Alzheimer DiseaseDamiano Archetti, Vikram Venkatraghavan, Béla Weiss, et al.
Alzheimer'S Research & Therapy|April 17, 2021
Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methodsJames D Doecke, Cindy Francois, Christopher J Fowler, et al.
Pageof 26